"Prospective Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
| Descriptor ID |
D011446
|
| MeSH Number(s) |
E05.318.760.500.750.625 N05.715.360.775.175.250.630 N06.850.520.450.500.750.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prospective Studies".
Below are MeSH descriptors whose meaning is more specific than "Prospective Studies".
This graph shows the total number of publications written about "Prospective Studies" by people in this website by year, and whether "Prospective Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 5 | 5 |
| 2010 | 0 | 7 | 7 |
| 2011 | 0 | 7 | 7 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 9 | 9 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 8 | 8 |
| 2016 | 0 | 12 | 12 |
| 2017 | 0 | 13 | 13 |
| 2018 | 0 | 19 | 19 |
| 2019 | 0 | 17 | 17 |
| 2020 | 0 | 19 | 19 |
| 2021 | 0 | 13 | 13 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prospective Studies" by people in Profiles.
-
Association Between Maternal Breastmilk Microbiota Composition and Rotavirus Vaccine Response in African, Asian, and European Infants: A Prospective Cohort Study. J Infect Dis. 2023 08 31; 228(5):637-645.
-
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041). Eur J Cancer. 2023 05; 184:1-9.
-
Physical Activity and Risk of Major Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review and Meta-Analysis of Observational Studies. Diabetes Care. 2022 12 01; 45(12):3101-3111.
-
Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease. Genome Med. 2022 09 24; 14(1):110.
-
Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population. Nephrol Dial Transplant. 2022 09 22; 37(10):1916-1926.
-
Translational impact of omics studies in alopecia areata: recent advances and future perspectives. Expert Rev Clin Immunol. 2022 08; 18(8):845-857.
-
Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium. Cardiovasc Diabetol. 2022 06 09; 21(1):99.
-
Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study. Vasc Health Risk Manag. 2022; 18:335-346.
-
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam. Epilepsia. 2022 06; 63(6):1563-1570.
-
Blood copper and risk of cardiometabolic diseases: a Mendelian randomization study. Hum Mol Genet. 2022 03 03; 31(5):783-791.
MeSH information
